2008
DOI: 10.1016/j.bbrc.2008.02.069
|View full text |Cite
|
Sign up to set email alerts
|

Identification of E2F1 as a positive transcriptional regulator for δ-catenin

Abstract: Abstractδ-Catenin is upregulated in human carcinomas. However, little is known about the potential transcriptional factors that regulate δ-catenin expression in cancer. Using a human δ-catenin reporter system, we have screened several nuclear signaling modulators to test whether they can affect δ-catenin transcription. Among β-catenin/LEF-1, Notch1, and E2F1, E2F1 dramatically increased δ-catenin-luciferase activities while β-catenin/LEF-1 induced only a marginal increase. Rb suppressed the upregulation of δ-c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
31
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 21 publications
(33 citation statements)
references
References 25 publications
(16 reference statements)
2
31
0
Order By: Relevance
“…However, when injecting intravenously, metastasis frequencies were increased; even so, this is statistically insignificant (Rv/C, metastatic tumor formed in one out of five mice; Rv/δ, two out of five mice). Similarly, when we analyzed four prostate cancer cell lines with different metastatic potential (CWR22Rv-1, DU145, PC3, LNCaP), we found no correlation between metastatic potential and δ-catenin overexpression [43]. When cells were injected intravenously through a tail vein, they tended to form skin tumors and metastasize to different internal organs, including brain, lung and kidneys, to different extents (Kim et al, unpublished data).…”
Section: Resultsmentioning
confidence: 99%
“…However, when injecting intravenously, metastasis frequencies were increased; even so, this is statistically insignificant (Rv/C, metastatic tumor formed in one out of five mice; Rv/δ, two out of five mice). Similarly, when we analyzed four prostate cancer cell lines with different metastatic potential (CWR22Rv-1, DU145, PC3, LNCaP), we found no correlation between metastatic potential and δ-catenin overexpression [43]. When cells were injected intravenously through a tail vein, they tended to form skin tumors and metastasize to different internal organs, including brain, lung and kidneys, to different extents (Kim et al, unpublished data).…”
Section: Resultsmentioning
confidence: 99%
“…It is interesting and also paradoxical that δ-catenin expression levels in cancer-derived cell lines are generally moderate or minimal [74,75]. Its overexpression in prostate cancer cells altered tumor suppressor E-cadherin and p120 ctn distribution at the cell–cell junction [73], disrupted the normal monolayer in cell culture [76] and promoted prostate tumorigenesis in mice [76].…”
Section: Challenges On Most Fronts Of Anticancer Effortsmentioning
confidence: 99%
“…Furthermore, examination of human EST data bank revealed δ- catenin mRNA sequences in prostate, kidney, ovarian, brain, breast, and esophageal tumors. Altered expression of δ-catenin was associated with cancer formation [16, 25], and Pax6 enhanced δ-catenin expression in prostate cancer cells [26]. In this study, we demonstrate, for the first time, that Pax6(+5a) and Pax6(−5a) regulate δ-catenin expression in an isoform- and dose-sensitive manner, but δ-catenin also exerts a feedback suppression on Pax6 with important implications in cellular morphogenesis, apoptosis, and cancer.…”
Section: Introductionmentioning
confidence: 99%